Radical innovation from the confluence of technologies: Innovation management strategies for the emerging nanobiotechnology industry

Journal of Engineering and Technology Management - JET-M

Volumn 32, Issue , 2014, Pages 1-25

  Maine, Elicia ^a   Thomas, V J ^a   Utterback, James ^b  

^a SIMON FRASER UNIVERSITY   (Canada)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Confluence of technologies; Nanotechnology biotechnology commercialization; Opportunity creation; Radical innovation; Technology convergence

Indexed keywords

INNOVATION;

INNOVATION MANAGEMENT; OPPORTUNITY CREATION; RADICAL INNOVATION; TECHNOLOGY CONVERGENCE;

TECHNOLOGY;

EID: 84902279844     PISSN: 09234748     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jengtecman.2013.10.007     Document Type: Article

References (128)

1. W. Abernathy, and J. Utterback Patterns of industrial innovation Technology Review 80 7 1978 40 47
2. R. Ackoff Ackoff's Best 1999 Wiley, New York New York, USA
3. R. Ackoff Disciplines, the two cultures, and The Scianities Systems Research and Behavioral Science 16 6 1999 533 537
4. R. Adner, and D. Levinthal The emergence of emerging technologies California Management Review 45 1 2002 50 66 (Pubitemid 36044777)
5. S. Aggarwal What's fueling the biotech engine - 2011 to 2012 Nature Biotechnology 30 12 2012 1191 1197
6. T.M. Allen, and P.R. Cullis Drug delivery systems: entering the mainstream Science 303 2004 1818 1822 (Pubitemid 38374867)
7. T. Allen, D. Lee, and M. Tushman R&D performance as a function of internal communication, project management and the nature of work IEEE Transactions on Engineering Management 27 1 1980 2 12
8. Aphios, 1999. Aphios US Patent for Drug Manufacturing Process That Rapidly & Selectively Manufactures Green Medicines. Available at http://www.aphios.com/news-and-current-events/press-releases-and-news/press-releases-archive/1999-press-releases/190-aphios-us-patent-for-drug-manufacturing-process-that-rapidly-selectively-manufactures-green-medicines.html (accessed on 31.08.13).
9. W. Arthur Competing technologies: an overview G. Dosi, C. Freeman, R. Nelson, G. Silverberg, L. Soete, Technological Change and Economic Theory 1988 Frances Pinter London 590 607
10. E. Avenel, A. Favier, S. Ma, V. Mangematin, and C. Rieu Diversification and hybridization in firm knowledge bases in nanotechnologies Research Policy 36 6 2007 864 870 (Pubitemid 46898552)
11. A.D. Bangham Liposomes: the Babraham connection Chemistry and Physics of Lipids 64 1993 275 285 (Pubitemid 23290879)
12. A.D. Bangham Surrogate cells or Trojan horses - the discovery of liposomes BioEssays 17 12 1995 1081 1088
13. ® - the first FDA-approved nano-drug: lessons learned Journal of Controlled Release 160 2012 117 134
14. A. Barirani, B. Agard, and C. Beaudry Discovering and assessing fields of expertise in nanomedicine: a patent co-citation network perspective Scientometrics 94 3 2013 1111 1136
15. N. Battard Convergence and multidisciplinarity in nanotechnology: laboratories as technological hubs Technovation 32 3-4 2012 234 244
16. M. Bliemel, and E. Maine Network embeddedness as a predictor of performance for new technology based firms International Journal of Technoentrepreneurship 1 3 2008 313 341
17. J. Brown, and J. Utterback Uncertainty and technical communication patterns Management Science 31 3 1985 301 311
18. P. Burgess, P.B. Hutt, O.C. Farokhzad, R. Langer, S. Minick, and S. Zale On firm ground: IP protection of therapeutic nanoparticles Nature Biotechnology 28 12 2010 1267 1270
19. A. Cambrosio, and P. Keating Between fact and technique: the beginnings of hybridoma technology Journal of the History of Biology 25 2 1992 175 230
20. L. Cardinal, and D. Hatfield Internal knowledge generation: the research laboratory and innovative productivity in the pharmaceutical industry Journal of Engineering and Technology Management 17 3-4 2000 247 271 (Pubitemid 32022742)
21. C. Carlsen Liposome Lands $28 Million in Stock Offering 1991, November 22 Liposome Technology Inc., San Francisco Business Times
22. P. Checkland Systems Thinking, Systems Practice 1981 Wiley Chichester, England
23. H. Chesbrough Open Innovation: The New Imperative for Creating and Profiting from Technology 2003 HBS Press Boston, MA, USA
24. C. Christensen The Innovator's Dilemma 1997 Harvard Business School Press Cambridge, MA, USA
25. D.W. Deamer From banghasomes to liposomes - a memoir of Alec Bangham, 1921-2010 FASEB Journal 24 2010 1308 1310
26. R. De Neufville Applied Systems Analysis: Engineering Planning and Technology Management 1990 McGraw-Hill New York, NY, USA
27. R.O. Dillman Antibodies as cytotoxic therapy Journal of Clinical Oncology 12 1994 1497 1515 (Pubitemid 24206251)
28. J. DiMasi, R. Hansen, and H. Grabowski The price of innovation: new estimates of drug development costs Journal of Health Economics 22 2003 151 185 (Pubitemid 36279392)
29. G. Dosi Sources, procedures, and microeconomic effects of innovation Journal of Economic Literature 26 3 1988 1120 1171
30. K. Eisenhardt, and J. Martin Dynamic capabilities: what are they? Strategic Management Journal 21 10/11 2000 1105 1121
31. R. Elmqvist Review of early pacemaker development Pacing & Clinical Electrophysiology 1 4 1978 535
32. J.G. Elvin, R.G. Couston, and C.F. van der Walle Therapeutic antibodies: market considerations, disease targets and bioprocessing International Journal of Pharmaceutics 440 2013 83 98
33. O.C. Farokhzad, and R. Langer Nanomedicine: developing smarter therapeutic and diagnostic modalities Advanced Drug Delivery Reviews 58 2006 1456 1459 (Pubitemid 44820502)
34. O.C. Farokhzad, and R. Langer Impact of nanotechnology on drug delivery ACS Nano 3 1 2009 16 20
35. D.B. Fenske, and P.R. Cullis Liposomal nanomedicines Expert Opinion on Drug Delivery 5 1 2008 25 44 (Pubitemid 351234108)
36. Financing Business Wall Street Journal 1987, May 20 pp. 57
37. L.M. Fisher Biotech plight: a cash shortage New York Times 1988, December 3 pp.35, 47
38. L.M. Fisher Sneaking past the immune system to deliver toxic drugs to tumors New York Times 1991, October 23 pp. D9
39. R. Foster Innovation: The Attacker's Advantage 1986 Summit Books New York, NY, USA
40. A.A. Gabizon Stealth liposomes and tumor targeting: one step further in the quest for the magic bullet Clinical Cancer Research 7 2001 223 225 (Pubitemid 32183021)
41. R. Garud, and M. Rappa A socio-cognitive model of technology evolution: the case of cochlear implants Organization Science 5 3 1994 344 362
42. R. Garud, and P. Karnoe Bricolage versus breakthrough: distributed and embedded agency in technology and entrepreneurship Research Policy 32 2 2003 277 301
43. J. Gertner The Idea Factory - Bell Labs and the Great Age of American Innovation 2012 Penguin Press New York, USA
44. S. Globe, G. Levy, and C. Schwartz Science, Technology and Innovation 1973 NSF-C 667, Battelle Columbus, Ohio, USA
45. S. Globe, G. Levy, and C. Schwartz Key factors and events in innovation process Research Management 16 4 1973 8 15
46. V. Gott Critical role of physiologist John A. Johnson in the origins of Minnesota's Billion Dollar Pacemaker Industry The Annals of Thoracic Surgery 83 1 2007 349 353 (Pubitemid 44917923)
47. A.J. Grillo-Lopez Rituximab: an insider's historical perspective Seminars in Oncology 27 6 2000 9 16 (Pubitemid 32164591)
48. A.J. Grillo-Lopez Rituximab: clinical development of the first therapeutic antibody for cancer O. Kayser, R.H. Muller, Pharmaceutical Biotechnology, Drug Discovery and Clinical Applications 2004 Weinheim Germany 213 230
49. S. Grodal, and G. Thoma Cross-Pollination in Science and Technology: Concept Mobility in the Nanobiotechnology Field 2009 http://www.gridthoma.info/papers/grodal-thoma-2009.pdf
50. F. Hacklin, C. Marxt, and F. Fahrni Coevolutionary cycles of convergence: an extrapolation from the ICT industry Technological Forecasting & Social Change 76 2009 723 736
51. G. Hamel, and C. Prahalad Competing for the Future 1994 Harvard University Press Boston, MA, USA
52. J. Hopps The development of the pacemaker Pacing and Clinical Electrophysiology 4 1 1981 106 108 (Pubitemid 11174560)
53. N. Hozumi, and S. Tonegawa Evidence for somatic rearrangement of immunoglobulin genes coding for variable and constant regions Proceedings of the National Academy of Sciences of the United States of America 73 10 1976 3628 3632
54. S.L. Jacobs Linkups with big companies help ease little guys' way Wall Street Journal 1985, July 15
55. A. Jaffe Technological opportunity and spillovers from R&D: evidence from firms' patents, profits and market value American Economic Review 76 5 1986 984 1001
56. E. Juanola-Feliu, J. Colomer-Farrarons, P. Miribel-Catala, J. Samitier, and J. Valls-Pasola Market challenges facing academic research in commercializing nano-enabled implantable devices for in-vivo biomedical analysis Technovation 32 2012 193 204
57. R. Kemp, and A. Rip Constructing transition paths through the management of niches R. Garud, P. Karnoe, Path Dependence and Creation 2001 LEA Mahwah, NJ, USA 269 299
58. A. Klevorick, R. Levin, R. Nelson, and S. Winter On the sources and significance of inter-industry differences in technological opportunities Research Policy 24 2 1995 185 205
59. C.S. Koehler Developing the ultracentrifuge Today's Chemist at Work February 2003 63 66
60. R. Langer A personal account of translating discoveries in an Academic Lab Nature Biotechnology 31 6 2013 487 489
61. D. Lasic, and D. Papahadjopoulos Liposomes revisited Science 267 1995 1275 1276
62. C. Lee, K. Lee, and J. Pennings Internal capabilities, external networks, and performance: a study on technology-based ventures Strategic Management Journal 22 6-7 2001 615 640 (Pubitemid 33612461)
63. R. Leifer, C. McDermott, G. O'Conner, L. Peters, M. Rice, and R. Veryzer Radical Innovation: How Mature Companies Can Outsmart Upstarts 2000 Harvard Business School Press Boston, Massachusetts, USA
64. D. Leonard Wellsprings of Knowledge: Building and Sustaining the Sources of Innovation 1995 Harvard Business School Press Boston, MA, USA
65. Liposome Technology Inc. Pact with erbamont set to develop cancer drug Wall Street Journal 1988, March 22 2
66. Liposome Technology Inc. Investor David Blech raises stake in concern to 25.9% Wall Street Journal 1990, March 2 B4A Eastern ed. [New York, NY]
67. C. Lok Nanotechnology: small wonders Nature 467 2010 18 21
68. M. Mackenzie, A. Cambrosio, and P. Keating The commercial application of a scientific discovery - the case of the hybridoma technique Research Policy 17 1988 155 170
69. E. Maine Radical innovation through internal corporate venturing: Degussa's commercialization of nanomaterials R&D Management 38 4 2008 359 371
70. E. Maine Scientist-Entrepreneurs as the catalysts of nanotechnology commercialization Reviews in Nanoscience and Nanotechnology 2 5 2013 300 305
71. E. Maine, and E. Garnsey Commercializing generic technology: the case of advanced materials ventures Research Policy 35 3 2006 375 393
72. E. Maine, M. Bliemel, A. Murira, and J. Utterback Knowledge Diversity in the Emerging Global Bio-Nano Sector. MIT ESD Working paper 2012 http://esd.mit.edu/wps/2012/esd-wp-2012-20.pdf
73. E. Maine, P.-H. Soh, and N. dos Santos Decision-making processes in biotech commercialization: constraints to effectuation. Technology Management for Emerging, Technologies PICMET 2012 Proceedings, IEEE XPlore 2012 http://ieeexplore.ieee.org/xpls/abs-all.jsp?arnumber=6304080&tag=1
74. E. Maine, V.J. Thomas, M. Bliemel, A. Murira, and J. Utterback The emergence of the nanobiotechnology industry Nature Nanotechnology 9 1 2014 2 5
75. L. Marks The birth pangs of monoclonal antibody therapeutics - the failure and legacy of centoxin MAbs 4 3 2012 403 412
76. D.E. Milenic, E.D. Brady, and M.W. Brechbiel Antibody-targeted radiation cancer therapy Nature Reviews Drug Discovery 3 2004 489 498
77. G. Moore Inside the Tornado 1995 Harper Collins New York, NY, USA
78. J. Morton Organizing for Innovation 1971 McGraw-Hill New York, NY, USA
79. P. Mueller, D.O. Rudin, H.T. Tien, and W.C. Wescott Reconstitution of excitable cell membrane structure in vitro Circulation 26 1962 1167 1171
80. R. Nelson, and S. Winter An Evolutionary Theory of Economic Change 1982 Harvard University Press Cambridge, MA, USA
81. H.J. No, and Y. Park Trajectory patterns of technology fusion: trend analysis and taxonomical grouping in nanobiotechnology Technological Forecasting and Social Change 77 2010 63 75
82. M. Patlak Magic Bullets and Monoclonals: An Antibody Tale 2009 FASEB Breakthroughs in Bioscience Bethesda, MD
83. D. Peer, J.M. Karp, S. Hong, O.C. Farokhzad, R. Margalit, and R. Langer Nanocarriers as an emerging platform for cancer therapy Nature Nanotechnology 2 2007 751 760 (Pubitemid 350223348)
84. R. Pei, and A.L. Porter Profiling leading scientists in nanobiomedical science: interdisciplinarity and potential leading indicators of research directions R&D Management 41 3 2011 288 306
85. E. Penrose The Theory of the Growth of the Firm 1959 Basil Blackwell Oxford, UK
86. G. Pisano Science Business: The Promise, the Reality, and The Future of Biotech 2006 Harvard Business Press Cambridge, MA, USA
87. G. Pisano The evolution of science-based business Industrial and Corporate Change 19 2 2010 465 482
88. G. Poste Liposome targeting in vivo: problems and opportunities Biology of the Cell 47 1 1983 19 38
89. T. Potterf, and E. Sorenson Winning Combination 2009 Seattle University Magazine available at http://www.seattleu.edu/magazine/article.aspx?id=21014&page=all (accessed 29.09.13)
90. W. Powell, K.W. Koput, and L. Smith-Doerr Interorganizational collaboration and the locus of innovation: networks of learning in biotechnology Administrative Science Quarterly 41 1 1996 116 145
91. I. Rafols Strategies for knowledge acquisition in bionanotechnology: why are interdisciplinary practices less widespread than expected? Innovation 20 4 2007 395 412
92. I. Rafols, and M. Meyer How cross-disciplinary is bionanotechnology? Explorations in the specialty of molecular motors Scientometrics 70 3 2007 633 650
93. W.H. Rastetter In An Interview Recorded by Matthew Shindell, San Diego, CA June 27, 2008 Available at http://libraries.ucsd.edu/assets/timeline/transcripts/rastetter-william-20080627.pdf
94. M. Riordan, and L. Hoddeson Crystal Fire: The Birth of the Information Age 1999 Norton New York, USA
95. E. Rogers Diffusion of Innovations 1983 Free Press New York, NY, USA
96. N. Rosenberg Science, invention and economic growth Economic Journal 84 333 1974 90 108
97. R. Rothwell Small firms, innovation and industrial change Small Business Economics 1 1 1989 51 64
98. J. Schumpeter The Theory of Economic Development 1934 Harvard University Press Boston, MA, USA
99. S. Shane Technological opportunities and new firm creation Management Science 47 2 2001 205 220 (Pubitemid 34192759)
100. S. Shane Finding Fertile Ground: Identifying Extraordinary Opportunities for New Ventures 2005 Wharton School Publishing NJ, USA
101. P. Sharp, and R. Langer Promoting convergence in biomedical science Science 333 6042 2011 527
102. P. Sharp et al. The Third Revolution: The Convergence of the Life Sciences, Physical Sciences, and Engineering 2011 [White paper on convergence, Massachusetts Institute of Technology (MIT), Washington, DC]
103. J. Snoek New Developments in Ferromagnetic Materials 1947 Elsevier Publishing Company Amsterdam, The Netherlands
104. P.-H. Soh Network patterns and competitive advantage before the emergence of a dominant design Strategic Management Journal 31 4 2010 438 461
105. S. Staff Reporter Liposome Technology Cuts Staff, Cites Merger Wall Street Journal 1989, March 27 B3A
106. Staff Reporter Guess Founder Quits as Chairman and CEO, Sells Stake to Brothers Wall Street Journal 1993, August 4 B2
107. T. Stijntjes, and B. Van Loon Scanning our past from the Netherlands: early investigations on ferrite magnetic materials by J.L. Snoek and Colleagues of the Philips Research Laboratories Eindhoven Proceedings of the IEEE 96 5 2008
108. W.R. Strohl Therapeutic monoclonal antibodies - past, present and future Z. An, Therapeutic Monoclonal Antibodies - From Bench to Clinic, New Jersey 2009 3 50
109. F. Suárez, and J. Utterback Dominant designs and the survival of firms Strategic Management Journal 16 6 1995 415 430
110. A. Subramanian, and P.-H. Soh An empirical examination of the science-technology relationship in the biotechnology industry Journal of Engineering and Technology Management 27 3-4 2010 160 171
111. J. Suzuki, and F. Kodama Technological diversity of persistent innovators in Japan: two case studies of large Japanese firms Research Policy 33 3 2004 531 541
112. Y. Takeda, S. Mae, Y. Kajikawa, and K. Matsushima Nanobiotechnology as an emerging research domain from nanotechnology: a bibliometric approach Scientometrics 80 1 2009 23 38
113. D. Teece Profiting from technological innovation: implications for integration, collaboration, licensing, and public policy Research Policy 15 6 1986 285 305
114. D. Teece, G. Pisano, and A. Shuen Dynamic capabilities and strategic management Strategic Management Journal 18 7 1997 509 534
115. S. Thomke Experimentation Matters: Unlocking the Potential of New Technologies for Innovation 2003 Harvard Business School Press Boston, MA, USA
116. V.P. Torchilin Targeted pharmaceutical nanocarriers for cancer therapy and imaging AAPS 9 2 2007 E128 E147
117. M. Tripsas Unravelling the process of creative destruction: complementary assets and incumbent survival in the typesetter industry Strategic Management Journal 18 1 1997 119 142 (Pubitemid 127697934)
118. M. Tushman, and P. Anderson Technological discontinuities and organizational environment Administrative Science Quarterly 31 3 1986 439 456
119. J. Utterback Mastering the Dynamics of Innovation 1994 Harvard Business School Press Boston, MA, USA
120. J. Utterback, and W. Abernathy A dynamic model of product and process innovation Omega 3 1975 639 656
121. E. von Hippel Democratizing innovation: the evolving phenomenon of user innovation Journal für Betriebswirtschaft 55 1 2001 63 78
122. V. Wagner, A. Dullart, A. Bock, and A. Zweck The emerging nanomedicine landscape Nature Biotechnology 24 2006 1211 1217 (Pubitemid 44564760)
123. L.M. Weiner, R. Surana, and S. Wang Monoclonal antibodies - versatile platforms for cancer immunotherapy Nature Reviews Immunology 10 2010 317 327
124. WSTS Semiconductor Market Forecast Spring 2013 2013 accessed at http://www.wsts.org/PRESS/Recent-News-Release on August 31, 2013
125. R.K. Yin Case Study Research: Design and Methods 2009 Sage CA, USA
126. S. Yoon, Y. Kim, H. Shim, and J. Chung Current perspectives on therapeutic antibodies Biotechnology and Bioprocess Engineering 15 2010 709 715
127. C. Zeller The Spatial Innovation Biography of a Commercially Successful Monoclonal Antibody 2008 Available at https://www.sbg.ac.at/gew/Zeller/WP/Espace%202008-5.pdf
128. L.G. Zucker, M.R. Darby, and M.B. Brewer Intellectual human capital and the birth of US biotechnology enterprises American Economic Review 88 1998 290 306 (Pubitemid 128452341)